ArticleJournal of experimental & clinical cancer research : CR2020

Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study.

Giulia Bon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.